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Postoperative Therapy after
Metacarpophalangeal ArthroplastyNicola Massy-Westropp,
BAppSc (OT), MHealth, CHT
Jegan Krishnan, MBBS, PhD, FRACS
Flinders Medical Centre
Bedford Park, AustraliaABSTRACT: A literature review was conducted to determine the
most effective postoperative therapy regimens for metacarpopha-
langeal (MCP) arthroplasty. The main difference between the
regimens was the use of passive MCP extension over active
extension and splinting in MCP flexion over splinting in
extension. One study did not find continuous passive motion to
be significantly beneficial for gaining hand strength or MCP
motion. No study evaluated the efficacy or suitability of
a particular regimen for specific implants or surgical procedures.
J HAND THER. 2003;16:311–314.Since the first metacarpophalangeal (MCP) im-
plant arthroplasties in the 1950s,1 more resurfacing
arthroplasties and excisional arthroplasties have
become available. Of the excisional arthroplasties,
one-piece and two-piece hinge designs, constrained
by screws or unconstrained, cemented and non-
cemented, have been designed.1 The original one-
piece silicone implants have an extended resting
position, whereas the more recent designs allow the
MCP joint to rest in slight flexion.1 More than 60
studies have been published about the procedure,
from case series and case studies to comparative
studies and randomized, controlled trials.
A number of prosthesis designs2 that allow flexion
and extension of the MCP joint are available. At the
time of implantation, synovectomy and soft-tissue
balancing procedures are often performed to increase
lateral joint stability or enhance the biomechanical
advantage of the tendons around the MCP joint.
These procedures include release of the tendons of
abductor digiti minimi and flexor digiti minimi,3
reconstruction of the radial collateral ligaments,4
centralization of the extensor digitorum tendon, and
transfer of the intrinsic insertions so that they provide
radial pull.5 Six comparative studies evaluated the
efficacy of various soft-tissue rebalancing procedures.
The efficacy of postoperative therapy regimens also
requires research. Joint stability andhand function are
the primary goals of therapy, 6 and regimens include
resting the hand, range-of-motion exercises, and
a progressive return to activity while incorporating
joint protection principles. Despite these common
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the splinting, exercises, and time frames between
the published regimens. The aim of this review is to
determine which postoperative regimen is most
effective in achieving these goals, and if anyparticular
regimen is best suited to a specific implant or soft-
tissue balancing procedure at the time of surgery.
METHOD
For inclusion in this review, studies had to evaluate
the efficacy of a post-MCP arthroplasty regimen for
patients who hadMCP arthroplasty with one or more
implants to the digits but not the thumb. All study de-
signs were accepted but expert opinion papers were
excluded. Patients may have received any type of im-
plant and soft-tissue procedure at the time of surgery.
Electronic databases searched were the Cochrane
Musculoskeletal Disease Group Register, PedRO,
Medline, CINAHL, EMBASE, Dissertations Ab-
stracts, EBM, DARE, Current Contents, and AMED.
No time or language limits were imposed.
Studies were appraised as described by the Coch-
rane Collaboration7 for sources of methodologic bias
that decrease the internal validity of a study. If the
study could not be fully appraised from the publica-
tion, informationwas soughtbywriting to theauthors.
RESULTS
Sixty-four studies that described the results ofMCP
arthroplasty were identified. The history of the
studies and their design is illustrated in Figure 1. Of
these studies, one randomized, controlled trial, two
case series, and two case studies were accepted for
this review. Although the remaining 59 studies
described outcomes for MCP arthroplasty, they were
not focused on the postoperative regimen.October–December 2003 311
All of the patients in the accepted studies had
rheumatoid arthritis; both genders were represented
and patients were in their third to seventh decade.
One outcome common of nearly all postoperative
patients in every study was the relief of pain once the
diseased joint had been removed by surgery. Nega-
tive outcomes such as prolonged swelling or implant
loosening were not reported.
Features common to all regimens (Table 1) were
postoperative avoidance of any hand activity for the
first four to six weeks and long-term avoidance of
ulnar forces on the fingers. All regimens began be-
tween the second and seventh postoperative day.
Regimens could be divided into two main catego-
ries with regard to splinting and exercise. Static splint
regimens involved removal of the splint for active
MCP range-of-motion exercises, and dynamic splint
regimens involved active-assisted MCP extension
and active MCP flexion exercises within the splint
(Table 1).
DISCUSSION
Five studies described the outcome of different
postoperative therapy regimes for MCP arthroplasty.
Two of these studies compared the efficacy of one
regimen over another, one of these being prospective.
Hand therapy for other conditions such as flexor
tendon repair also offers multiple postoperative
regimens. For example, healing tendons of the hand
usually receive motion, but it may be passive, active,
or a combination of all of these.8 The rationale for the
various exercise regimens is based on biological
healing of the tendon and the strength of the surgical
repair, thus its ability to withstand stress without
rupturing or forming a gap.9 These patients usually
have normal and similar anatomy preoperatively,
leaving few patient variables.
Postoperative therapy regimens for MCP arthro-
plasty are also based on principles of healing and
scar formation,6 but are not prescribed according to
the patient’s preoperative hand impairment, the type
of implant used, or soft tissue balancing procedures
FIGURE 1. The history of metacarpophalangeal arthroplasty
study design. RCT, randomized controlled trial.312 JOURNAL OF HAND THERAPYperformed. For example, patients having undergone
extensor tendon rebalancing and recentralization
may benefit from avoidance of passive flexion or
avoidance of the extremes of flexion, much like a
postoperative extensor tendon repair may be treated.
The literature suggests that postoperative therapy for
MCP arthroplasty has not been prescribed in this
manner; rather, each protocol has been carefully
designed and applied to consecutive patients.
To compare the efficacy of a new protocol, many
patients would be required for allocation to various
postoperative therapy groups. Their outcomeswould
have to be analyzed according to what protocol they
received with the implant, surgery, and preoperative
status as variables. The first difficulty in forming
control or comparison groups lies in the infrequency
of this procedure. Ring et al.10 took three years to
include 25 hands in their study, Pereira and Belcher,5
took three years for 43 hands and Vahvanen and
Viljakka11 took nine years for 37 hands.
The most common source of bias in the studies was
selection bias, which occurs when patients are chosen
for treatment or control groups as a result of char-
acteristics that are expected to affect their outcome.
Randomization is designed to control the confound-
ing effects of differences between subjects at base-
line,12 and the randomized trial is recommended as
the best method of determining treatment efficacy.
Here lies the second difficulty in forming control or
comparison groups. Patients undergo MCP arthro-
plasty at all stages of their disease, evidenced by the
wide range of motion deficits between the studies of
Burr and Pratt,13 in which the case study patient had
nearly normal preoperative MCP motion, and Burr
et al.,14 in which some patients had only 258 of MCP
flexion. Measures of pain also varied widely in the
latter study, ranging from ‘‘zero’’ to ‘‘eight out of ten.’’
These baseline measurements demonstrate the diffi-
culty in obtaining a homogeneous, comparable
group of patients with rheumatoid arthritis.
The other three sources of bias described by the
Cochrane Collaborationwere present in the reviewed
studies. Performance bias occurs when patients
receive a variation in duration, quality, or quantity
of the treatment being studied, which was suspected
in the continuous passive motion (CPM) study by
Ring et al.10 Ring et al. describe the application of
CPM in detail, except passive forces are described as
‘‘low’’ and treatment quantity is described as ‘‘as
tolerated.’’ As a result, the reader remains unsure of
what amount of passive force is ineffective, as well as
what quantity of treatment per day is ineffective.
Detection bias is determined if the timing of
assessment, the outcome assessment used, or knowl-
edge of the assessor of the patient’s previous state
could miss any relevant aspect of the outcome. This
may have occurred in the study by Groth et al.,15 in
which some preoperative data were unavailable and
CP) Arthroplasty
roth et al.15 Gribben et al.17
ve case series (n = 34
46 hands)
Case study (n = 1)
Day 4
Steffee prostheses
CP flexion splint Dynamic MCP extension and
flexion splint, 10/52
8 flexion. Static splint, MCP 08
MCP and IP ROM 3 4 daily in
splint
MCP and IP ROM
Return to work 10/52; avoid
forceful grasps and traction on
fingers
roup had significantly
P flexion than cohort,
ar MCP extension
Patient had 108 less MCP flexion
5 months post, but reduced
pain and paresthsias
ction, detection of all
s
Patient selection
O
cto
b
e
r–
D
e
ce
m
b
e
r
2003
313TABLE 1. Summary of Postoperative Therapy Regimens for Metacarpophalangeal (M
Regimen Burr et al.14 Burr and Pratt13 Ring et al.10 G
Design Case series (n = 15) Case study (n = 1) RCT (n = 25) Retrospecti
patients,
Started Day 5–7 Day 5 Day 2–7 Not known
Implant Swanson prostheses Swanson prostheses ‘‘Silicone arthroplasty’’ Not known
Day splint Two static splints, alternated 24 hourly, with MCP
at 08 in one splint and at 60 in the other for 4/52;
biofeedback to finger flexors and extensors at 3/52
Dynamic MCP extension splint
with RD, 6/52*
Dynamic M
Night splint As above MCP 08 for 12/52 MCP 20–30
Active exercise Wrist, MCP, and IP ROM, RD
3 10 every hour for 4/52
MCP and IP ROM, radial
deviation 3 10 every hour for
the first 4 weeks
MCP and IP ROM 3 10 every
2 hours in splint; RD at 4/52
Not known
Passive exercise IP ROM , RD 3 10 hourly, MCP
flexion at 4/52
IP ROM, treatment group
received MCP CPM
Not known
Activity ‘‘Light activity’’ at 4/52, ‘‘normal activities of
daily living’’ at 8/52; return to work 12/52;
no function for 4/52, no heavy lifting until
12/52
No pinch for 12/52 Not known
Outcome X MCP flexion unchanged;
improvements in pain, MCP
extension, and power grip
0–158 MCP extension and 60–708
MCP flexion at 8/52
CPM group did not achieve
significant increases in ROM or
strength at 5/12z
Treatment g
more MC
but simil
Bias Patient selection, detection of all
outcomes
Detection of all outcomes
(preoperative data not
available)
Patient selection, performance of
treatment equally between
patients
Patient sele
outcome
*For 6/52 = six weeks.
y3/24 = three times daily.
z5/12 = 5 months.
IP, interphalangeal joints; RD, radial deviation; RCT, randomized controlled trial; ROM, range of motion.
patients were assessed at different postoperative
time frames. Detection and comparison of outcomes
between studies are only possible when the same
outcome measures are used in a standardized man-
ner. The researchers in this review all measured range
ofmotion, but at different time frames (Table 1). Those
who measured pain, cosmesis, and function applied
different assessments at different time frames. The
challenge of outcome measurement in rheumatology
has led to the formation of focus groups such as
OMERACT (Outcome Measures in Rheumatoid
Arthritis Clinical Trials), who have made recommen-
dations for outcome measures to be used in drug
trials.16 OMERACT recommendations are not fully
relevant to hand therapy research; however, the
process of forming a focus group, and the develop-
ment of assessment guidelines that allow comparison
between homogeneous patients, is possible.
Attrition bias is determined if the loss of patients in
the study is significant or varies between the
treatment and control groups. This is common in
long-term studies involving patients with rheuma-
toid arthritis, and was experienced by Groth et al.,15
who were unable to obtain long-term follow-up of
the patient group who received their extension
protocol. Long-term follow-up is an issue with
rheumatoid populations. These patients undergo
numerous surgical and drug interventions, while
their disease progresses and fluctuates, making the
long-term effects of the MCP surgery and therapy
difficult to define. Once more, large numbers of
patients in each treatment group would be required
to decrease the effects of attrition bias and to dilute
the effects of subsequent interventions.
The difficulties of past studies guide the planning
of future studies. Although the issues of low patient
numbers, variable preoperative status, additional
surgical and drug interventions, and chronic disease
cannot be altered, study designs can. Large random-
ized trials may not be possible; however, samples of
patients, paired according to preoperative status,
may be allocated to different treatment protocols.
Standardized measurement of pain, cosmesis, im-
pairment, disability, and impact on the patient, made
at similar postoperative time frames, would further
assist in determining treatment efficacy. Future
research by the author endeavors to determine the
most relevant outcome measures and time frames for
post-MCP arthroplasty patients.
CONCLUSION
This review suggests that all regimens contribute
toward an increase in MCPmotion and an increase in
hand function, but despite the efforts of patients and
clinicians, hand therapists remain unaware of the314 JOURNAL OF HAND THERAPYmost effective postoperative protocol for MCP
arthroplasty or the suitability of each regimen for
specific implants and soft-tissue procedures. Diffi-
culties in researching this topic include low patient
numbers, highly variable preoperative status, lack of
guidelines for outcome measures and time frames,
and the effects of subsequent interventions received
by the patient. The nature and size of the population
with rheumatoid arthritis and MCP arthroplasty do
not readily fit the randomized, controlled trial
design. Paired sample designs are suggested, as well
as the formation of standard outcome measures, for
better comparison of results between patients.
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